EPA-Approved SARS-CoV-2 Disinfectants
4 rows where Formulation_type contains "Solid" and Use_site contains "Institutional" sorted by Formulation_type
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient, Contact_time, Why_on_List_N
ID
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type ▼
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1189 |
70060-19 |
Increased Risk |
Sodium chlorite; Sodium dichloroisocyanurate dihydrate |
Aseptrol S10-Tab |
BASF Corporation |
Healthcare; Institutional |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
1.0 minutes |
Solid |
SARS-CoV-2 |
2021-08-24 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1287 |
69470-37 |
Increased Risk |
Sodium dichloroisocyanurate |
Clearon Bleach Tablets |
Clearon Corporation |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
10.0 minutes |
Solid |
Canine parvovirus |
2020-05-14 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1324 |
66570-2 |
Increased Risk |
Sodium dichloroisocyanurate |
EfferSan™ |
Activon Inc |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
5.0 minutes |
Solid |
Feline calicivirus |
2020-04-23 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1525 |
74986-5 |
Increased Risk |
Sodium chlorite |
Selectrocide 5g |
Selective Micro Technologies LLC |
Healthcare; Institutional |
Hard Nonporous (HN) |
10.0 minutes |
Solid |
Human coronavirus |
2020-03-13 |
Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |